Biomarker-Guided Therapy Partnership: Supporting Molecular Testing Infrastructure for Colorectal Cancer
Delta Medical collaborates with Amgen and CSD LAB to support molecular diagnostic infrastructure for metastatic colorectal cancer treatment in Ukraine. Through a national testing network, we help oncology teams access extended RAS testing, a prerequisite for determining eligibility for certain targeted therapies. This collaborative model aligns Ukraine’s oncology diagnostic capabilities with international standards and creates […]











